T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
First Financial Corp
THFF
$975M
| $565K | ﹤0.01% |
12,559
+902
| +8% | +$38.4K |
|
|
CSII
2302
DELISTED
Cardiovascular Systems, Inc.
CSII
| $564K | ﹤0.01% |
14,720
-1,080
| -7% | -$46K |
|
|
ALX
2303
Alexander's
ALX
$1.4B
| $563K | ﹤0.01% |
2,030
-94
| -4% | -$26.1K |
|
2304
Scansource
SCSC
$1.06B
| $563K | ﹤0.01% |
18,799
-4,028
| -18% | -$117K |
|
2305
Accuray
ARAY
$32.9M
| $562K | ﹤0.01% |
113,495
-14,160
| -11% | -$73K |
|
2306
Univest Financial
UVSP
$1.19B
| $562K | ﹤0.01% |
19,651
+4,403
| +29% | +$112K |
|
|
CYBE
2307
DELISTED
Cyberoptics Corp
CYBE
| $560K | ﹤0.01% |
21,549
+9,843
| +84% | +$256K |
|
2308
Mitek Systems
MITK
$853M
| $559K | ﹤0.01% |
38,328
-5,312
| -12% | -$85.3K |
|
2309
iShares Biotechnology ETF
IBB
$9.77B
| $558K | ﹤0.01% |
3,703
+89
| +2% | +$14.1K |
|
2310
Motorcar Parts of America
MPAA
$235M
| $556K | ﹤0.01% |
24,697
+15
| +0.1% | +$330 |
|
|
MRC
2311
DELISTED
MRC Global
MRC
| $552K | ﹤0.01% |
61,112
-34,269
| -36% | -$292K |
|
|
MSGN
2312
DELISTED
MSG Networks Inc.
MSGN
| $549K | ﹤0.01% |
36,526
+19,481
| +114% | +$326K |
|
2313
Gevo
GEVO
$401M
| $548K | ﹤0.01% |
+55,900
| New | +$536K |
|
2314
Oxford Industries
OXM
$542M
| $547K | ﹤0.01% |
6,256
-17
| -0.3% | -$1.31K |
|
|
EBIX
2315
DELISTED
Ebix Inc
EBIX
| $547K | ﹤0.01% |
17,090
-15
| -0.1% | -$579 |
|
2316
Enterprise Financial Services Corp
EFSC
$2.4B
| $546K | ﹤0.01% |
11,046
-10
| -0.1% | -$421 |
|
2317
Evolus
EOLS
$530M
| $543K | ﹤0.01% |
+41,784
| New | +$385K |
|
2318
Purple Innovation
PRPL
$28.7M
| $541K | ﹤0.01% |
+683
| New | +$593K |
|
2319
Shutterstock
SSTK
$217M
| $541K | ﹤0.01% |
6,073
+1,876
| +45% | +$150K |
|
|
VAPO
2320
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $541K | ﹤0.01% |
2,816
+691
| +33% | +$160K |
|
|
HOME
2321
DELISTED
At Home Group Inc.
HOME
| $541K | ﹤0.01% |
18,854
+5,798
| +44% | +$146K |
|
|
MIK
2322
DELISTED
Michaels Stores, Inc
MIK
| $541K | ﹤0.01% |
24,664
-6,791,956
| -100% | -$120M |
|
2323
Ocular Therapeutix
OCUL
$2.22B
| $540K | ﹤0.01% |
32,901
+6,973
| +27% | +$134K |
|
|
DEA
2324
Easterly Government Properties
DEA
$1.18B
| $538K | ﹤0.01% |
10,374
-857
| -8% | -$47.2K |
|
2325
Hingham Institution for Saving
HIFS
$686M
| $538K | ﹤0.01% |
1,895
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.